Irish drug that could cure Parkinson’s Disease sold for $446 million

Dr. Jeremy Skillington, Vice President of Business Development for Inflazome, travelled to Philadelphia to participate in our Life Sciences Forum this January. In one of the largest deals in Irish biotech history, Inflazome, based out of Trinity, has been sold to Roche.

The Dublin-based drug sells opening treatment of Alzheimer’s, Parkinson’s, and cardiovascular disease to the market.

An Irish company that develops treatments for inflammatory diseases, a collaboration between Trinity College Dublin and the University of Queensland, has been sold for an up-front payment of $446m (€380m) from Roche, plus additional payments based on the achievement of certain milestones.

Read More

The Irish Echo

Last year, two million visitors from North America visited the Emerald Isle.

That stunning figure – fully one-in-ten of all Americans who travelled to Europe on vacation made Ireland their destination — was the fruits of two decades of hard work by Tourism Ireland, the cross-border agency set up as part of the 1998 Good Friday Agreement.

Fast forward to the summer of 2020, however, and, courtesy of our new lodger Covid-19, the total number of American holiday-makers in Ireland would hardly fill a Paddywagon tour bus.

For while there is no complete ban on travellers from the US travelling to Ireland — though that option is being mulled over in government corridors in Dublin — the necessity to quarantine for 14 days on arrival means only the bravest, long-stay vacationers are boarding the EI 104 from JFK to Dublin.

Read More

Saddened by the loss of John Hume, the Consulate General of Ireland in NY has opened a virtual book of condolence for those in New York, New Jersey, Pennsylvania, Delaware and beyond who might wish to share their sympathies with his family.